April 2019

April 9, 2019 - Press Releases

IGEM Therapeutics appoints Dr David Chiswell as a Non-Executive Chairman

April 9, 2019 0 0 0

Cambridge Antibody Technology co-founder and CEO, Dr Chiswell brings 30 years of biotechnology experience to IGEM Therapeutics’s Board London, 9 April 2019 – IGEM Therapeutics (IGEM), an immuno-oncology company developing novel immunoglobulin E...

April 2, 2019 - Press Releases

IGEM Therapeutics announces further UK government funding to develop novel IgE antibody targeting solid tumours expressing HER2

April 2, 2019 0 0 0

Company receives grant from Innovate UK Biomedical Catalyst Primer Award London, 2 April 2019 – IGEM Therapeutics (IGEM), an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer, today announced the award of...